Document is current
Any future updates will be listed below
-
Authors
Yadav, Surekha
Tuchayi, Abuzar Moradi
Moradpour, Moein
Jiang, Fei
Juarez, Roxanna
de Kouchkovsky, Ivan
Flavell, Robert R.
Aggarwal, Rahul R.
Hope, Thomas A. https://orcid.org/0000-0002-2228-5823
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA235741)
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 24 March 2025
First Online: 7 April 2025
Declarations
:
: The institutional review board approved this retrospective study and the requirement to obtain informed consent was waived.
: The requirement to obtain informed consent was waived.
: Not applicable.
: Thomas Hope has grant funding to the institution from Clovis Oncology, GE Healthcare, Lantheus, Janssen, the Prostate Cancer Foundation, Telix, and the National Cancer Institute (R01CA235741 and R01CA212148). He received personal fees from Bayer and BlueEarth Diagnostics, Lantheus and received fees from and has an equity interest in Curium.
